{
  "profile_url": "https://www.moffitt.org/research-science/researchers/taiga-nishihori/",
  "last_updated": "2025-11-21T22:50:27.061392",
  "researcher_id": "7659",
  "degrees": [
    "MD"
  ],
  "title": "",
  "primary_program": "blood and marrow transplant and cellular immunotherapy",
  "research_program": "molecular medicine",
  "overview": "Dr. Nishihori's research focuses on the improvement of clinical outcomes after hematopoietic cell transplantation (HCT) and cellular immunotherapy through application of novel treatment approaches. He is interested in evaluating the outcome measures after transplant and cellular therapy for various hematologic malignancies.",
  "research_interests": [
    "My research interests are application of novel strategies to improve hematopoietic cell transplantation (HCT) and cellular therapy outcomes in hematologic malignancies. Disease focus includes leukemia, lymphoma, multiple myeloma as well as myeloproliferative neoplasms such as myelofibrosis. He has served as data director at BMT CI department and has participated in number of studies conducted by the Center for International Blood and Marrow Transplant Research (CIBMTR). He has over 200 peer reviewed publications. He serves as a co-chair of Plasma Cell Disorders Working Committee at CIBMTR since 2023.\n  *"
  ],
  "associations": [
    "Blood and Marrow Transplant and Cellular Immunotherapy",
    "Pentecost Family Myeloma Research Center",
    "Molecular Medicine Program"
  ],
  "education": [
    {
      "type": "Medical School",
      "institution": "Hokkaido University",
      "degree": "MD"
    },
    {
      "type": "Internship",
      "institution": "US Naval Hospital Yokusuka",
      "position": "Intern"
    },
    {
      "type": "Residency",
      "institution": "Beth Israel Medical Center",
      "position": "Intern",
      "specialty": "al Medicine"
    },
    {
      "type": "Residency",
      "institution": "Beth Israel Medical Center",
      "specialty": ""
    },
    {
      "type": "Residency",
      "institution": "Hokkaido University Hospital",
      "specialty": "Radiation Oncology & Diagnostic Radiology"
    },
    {
      "type": "Fellowship",
      "institution": "Yale University",
      "specialty": "Medical Oncology"
    },
    {
      "type": "Fellowship",
      "institution": "Moffitt Cancer Center",
      "specialty": "Blood and Marrow Transplantation"
    },
    {
      "type": "Board Certification",
      "institution": "Internal Medicine",
      "certification": "Hematology"
    }
  ],
  "publications": [
    {
      "title": "Allogeneic haematopoietic cell transplantation in advanced systemic mastocytosis in new era: A CIBMTR study",
      "pubmed_id": "40983528",
      "pmc_id": "PMC12519450",
      "year": "2025",
      "publication_date": "2025 Sep",
      "authors": "Ustun C, Zhang MJ, Peterson A, Baek A, Agha M, Alkhateeb H, Chhabra S, Coltoff A, de Lima M, Gandhi A, Ho V, Kassim A, Lin A, Gowda L, Borthakur G, DeAngelo DJ, McGuirk J, Mensah F, Nadiminti KV, Nishihori T, Pantin J, Trunk A, Uberti J, Marcucci G, Gotlib J, Akin C, Hamadani M, Pullarkat V, Valent P, Grunwald M, Juckett M, Oran B, Saber W, Burns LJ",
      "journal": "Brit J Haematol"
    },
    {
      "title": "Phase II Trial of Reduced-Intensity Fludarabine, Melphalan, and Total Body Irradiation Conditioning With Haploidentical Donor Peripheral Blood Stem Cell Transplant",
      "pubmed_id": "40492500",
      "year": "2025",
      "publication_date": "2025 Sep",
      "authors": "Elmariah H, Kim J, Gonzalez R, DiMaggio E, Sansil S, Mishra A, Faramand R, Perez L, Lazaryan A, Mirza AS, Khimani F, Liu H, Ochoa-Bayona JL, Nieder M, Perna F, Figura N, Robinson TJ, Nishihori T, Anasetti C, Pidala JA, Bejanyan N",
      "journal": "Am J Hematol"
    },
    {
      "title": "Letermovir reduces cytomegalovirus in HLA-matched and mismatched allogeneic hematopoietic cell transplant patients receiving post-transplant cyclophosphamide",
      "pubmed_id": "40617898",
      "year": "2025",
      "publication_date": "2025 Oct",
      "authors": "Schmitz J, Gaskill E, Price S, Cao B, Kim J, Baluch A, Klinkova O, Faramand R, Mishra A, Perez L, Khimani F, Lazaryan A, Ochoa-Bayona JL, Liu H, Mirza AS, Nieder M, Anasetti C, Nishihori T, Pidala JA, Bejanyan N, Elmariah H",
      "journal": "Bone Marrow Transplant"
    },
    {
      "title": "Impact of Obesity and Weight-Based Chemotherapy Dosing Adjustments on Outcomes of Allogeneic Hematopoietic Cell Transplant for Acute Myeloid Leukemia",
      "pubmed_id": "41115629",
      "year": "2025",
      "publication_date": "2025 Oct",
      "authors": "Gaskill E, Albanyan O, Naqvi SMH, Mo Q, Belfon A, Nishihori T, Faramand R, Lazaryan A, Hansen DK, Khimani F, Mishra A, Nieder M, Perez L, Liu H, Pidala J, Anasetti C, Bejanyan N, Elmariah H",
      "journal": "Transplant Cell Ther"
    },
    {
      "title": "Infection after CD19 chimeric antigen receptor T cell therapy for large B cell lymphoma: Real-world analysis from CIBMTR",
      "pubmed_id": "40435511",
      "year": "2025",
      "publication_date": "2025 May",
      "authors": "Wudhikarn K, Herr MM, Chen M, Martens MJ, Baird JH, Gowda L, Rangarajan HG, Abid MB, Kharfan-Dabaja MA, Williams KM, Ganguly S, Young JH, Sharma A, Fatobene G, Jain T, Kanakry CG, Modi D, Grover NS, Salem B, Batista MV, Vergidis P, Yin DE, Beitinjaneh AM, Kelkar AH, Nishihori T, Holter-Chakrabarty J, Gergis U, Smith M, El Boghdadly Z, Dandoy CE, Murthy HS, Huppler AR, Perales MA, Chemaly RF, Hill JA, Riches M, Auletta JJ",
      "journal": "Blood Adv"
    },
    {
      "title": "Whole-body MRI for a patient with progressive multiple myeloma",
      "pubmed_id": "40386466",
      "pmc_id": "PMC12085220",
      "year": "2025",
      "publication_date": "2025 May",
      "authors": "Henning JE, Nishihori T, Freeman C, Lazarides A, Song J, Kuruvilla D, Feuerlein S, Costello JR",
      "journal": "BJR Case Rep"
    },
    {
      "title": "Standard-of-care idecabtagene vicleucel for relapsed/refractory multiple myeloma",
      "pubmed_id": "40198886",
      "year": "2025",
      "publication_date": "2025 Jul",
      "authors": "Sidana S, Ahmed N, Akhtar OS, Brazauskas R, Oloyede T, Bye M, Hansen DK, Ferreri CJ, Freeman CL, Afrough A, Anderson LD, Dhakal B, Dhanda DS, Gowda L, Hashmi H, Harrison MJ, Kitali A, Landau HJ, Mirza AS, Patwardhan P, Qazilbash MH, Usmani SZ, Patel KK, Nishihori T, Ganguly S, Pasquini MC",
      "journal": "Blood"
    },
    {
      "title": "Sarcopenia and Skeletal Muscle Loss after CAR T-cell Therapy in Diffuse Large B-cell Lymphoma",
      "pubmed_id": "40238583",
      "pmc_id": "PMC12213223",
      "year": "2025",
      "publication_date": "2025 Jul",
      "authors": "Jhaveri K, Thapa R, Ercan D, Saha A, Noble J, Singh P, Fahrmann J, Saini N, Wu R, Dennison JB, Hanash S, Jenq RR, Modi K, Figura N, Chavez J, Shah B, Nishihori T, Lazaryan A, Khimani F, Bachmeier C, Gage K, Mishra A, Perna F, Davila ML, Spiegel J, Rejeski K, Subklewe M, Locke FL, Freeman C, Parker N, Jain MD",
      "journal": "Clin Cancer Res"
    },
    {
      "title": "Cytokine Release Syndrome and Neurotoxicity Following CD19 CAR-T in B-Cell Lymphoma",
      "pubmed_id": "40288610",
      "year": "2025",
      "publication_date": "2025 Jul",
      "authors": "Shouval R, Strouse C, Kim S, Oloyede T, Ahmed S, Awan FT, Luan D, Bachanova V, Badar T, Bar M, Barba P, Beitinjaneh AM, Cashen A, Dholaria B, Elsawy M, Ganguly S, Geethakumari PR, Greenbaum U, Hashmi H, Hill LC, Jain MD, Jain T, Kebriaei P, Kittai AS, Locke FL, Lulla PD, Mead E, McGuirk JP, Mussetti A, Nishihori T, Olson AL, Pennisi M, Perales MA, Riedell PA, Saber W, Mirza AS, Magalhaes-Silverman M, Shpall EJ, Sorror M, Wudhikarn K, Turtle CJ, Moskop A, Pasquini MC",
      "journal": "Transplant Cell Ther"
    },
    {
      "title": "The Functional Transcriptomic Landscape Informs Therapeutic Strategies in Multiple Myeloma",
      "pubmed_id": "39476082",
      "pmc_id": "PMC11733535",
      "year": "2025",
      "publication_date": "2025 Jan",
      "authors": "Sudalagunta PR, Canevarolo RR, Meads MB, Silva M, Zhao X, Cubitt CL, Sansil SS, DeAvila G, Alugubelli RR, Bishop RT, Tungesvik A, Zhang Q, Hampton O, Teer JK, Welsh EA, Yoder SJ, Shah BD, Hazlehurst L, Gatenby RA, Van Domelen DR, Chai Y, Wang F, DeCastro A, Bloomer AM, Siegel EM, Lynch CC, Sullivan DM, Alsina M, Nishihori T, Brayer J, Cleveland JL, Dalton W, Walker CJ, Landesman Y, Baz R, Silva AS, Shain KH",
      "journal": "Cancer Res"
    }
  ],
  "grants": [
    {
      "description": "Title: A Phase II Randomized Controlled Trial Comparing GVHD-Reduction Strategies for Allogeneic Peripheral Blood Transplantation (PBSCT) for Patients with Acute Leukemia  \nAward Number: P015P01CA018029-47  \nSponsor: National Cancer Institute (NCI)  \nNishihori, T. (PD/PI)",
      "title": "A Phase II Randomized Controlled Trial Comparing GVHD-Reduction Strategies for Allogeneic Peripheral Blood Transplantation (PBSCT) for Patients with Acute Leukemia",
      "award_number": "P015P01CA018029-47",
      "sponsor": "National Cancer Institute (NCI)",
      "source": "NCI",
      "investigators": [
        {
          "name": "Nishihori, T.",
          "role": "PD/PI"
        }
      ]
    }
  ],
  "participating_trials": [
    {
      "trial_url": "https://www.moffitt.org/clinical-trials-and-studies/clinical-trial-20632/",
      "trial_id": "20632",
      "title": "A Phase II Randomized Controlled Trial Comparing GVHD-Reduction Strategies for Allogeneic Peripheral Blood Transplantation (PBSCT) for Patients with Acute Leukemia or Myelodysplastic Syndrome: Selective Depletion of CD45RA+ Na\u00efve T Cells (TND) vs. Post-Transplantation Cyclophosphamide (PTCy)",
      "condition": "Malignant Hematology",
      "intervention": "FK506 (Tacrolimus); MESNA (); PBSC (); Tacrolimus (); Thiotepa (Thioplex); busulfan (); cyclophosphamide (); cytoxan (cyclophosphamide); fludarabine (Fludarabine phosphate); methotrexate ()",
      "status": "Open"
    },
    {
      "trial_url": "https://www.moffitt.org/clinical-trials-and-studies/clinical-trial-22461/",
      "trial_id": "22461",
      "title": "A First-in-Human Study of HLA-Partially to Fully Matched Allogenic Cryopreserved Deceased Donor Bone Marrow Transplantation for Patients with Hematologic Malignancies",
      "condition": "Malignant Hematology",
      "intervention": "Alkeran (Melphalan); Melphalan (); Ossium HPC (); Radiotherapy (); busulfan (); cyclophosphamide (); cytoxan (cyclophosphamide); fludarabine (Fludarabine phosphate)",
      "status": "Open"
    },
    {
      "trial_url": "https://www.moffitt.org/clinical-trials-and-studies/clinical-trial-22538/",
      "trial_id": "22538",
      "title": "A Phase 1/2a Multicenter Ascending Dose Study to Evaluate the Safety of HA-1 Minor Histocompatibility Antigen-Reactive TCR-Modified T Cells (BSB-1001) in Patients Undergoing HLA-Matched Allogenic Hematopoietic Stem Cell Transplant for AML, ALL or MDS",
      "condition": "Malignant Hematology",
      "intervention": "Alkeran (Melphalan); BSB-1001 (); Melphalan (); Radiotherapy (); Thiotepa (Thioplex); busulfan (); fludarabine (Fludarabine phosphate)",
      "status": "Open"
    }
  ],
  "lab_page_url": "",
  "google_scholar_url": "https://scholar.google.com/citations?user=7XnjuzoAAAAJ&hl=en",
  "photo_url": "https://www.moffitt.org/globalassets/images/researchers_bio/NishihoriTaiga_7659.jpg",
  "contact": {
    "contact_url": "https://eforms.moffitt.org/ContactResearchersForm?PERID=7659"
  },
  "content_hash": "878d390ef64efc59ac221cfbc93cdbe26b1528086474d1ca226db098515d10ca",
  "researcher_name": "taiga nishihori",
  "department": ""
}